Literature DB >> 20722761

The roles of antigen-specificity, responsiveness to transforming growth factor-β and antigen-presenting cell subsets in tumour-induced expansion of regulatory T cells.

David Coe1, Caroline Addey, Matthew White, Elizabeth Simpson, Julian Dyson, Jian-Guo Chai.   

Abstract

In this study we investigated the impact of several factors on the expansion of natural regulatory T (nTreg) cells by tumours, including antigen specificity, transforming growth factor-β (TGF-β) signalling and the antigen-presenting cell subsets responsible for expansion. We found that antigen non-specific expansion of nTreg cells is tumour cell line-dependent. Although both antigen-specific and non-specific pathways can contribute to expansion, the migration of activated nTreg cells to tumour tissues is strictly antigen-dependent. Intact TGF-β signalling on nTreg cells is also essential for tumour-induced expansion. Finally, for stimulation of resting antigen-specific CD4 T cells, CD11c(+) cells purified from tumour-draining lymph nodes were more potent than CD11b(+) cells, suggesting that dendritic cells are the key antigen-presenting cell subset involved in cross-presentation of tumour antigens. This study not only provides an in vivo system in which cross-talk between nTreg cells and tumours can be explored but also reveals novel aspects of tumour immune evasion.
© 2010 The Authors. Immunology © 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20722761      PMCID: PMC2999806          DOI: 10.1111/j.1365-2567.2010.03328.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Tumor antigens are constitutively presented in the draining lymph nodes.

Authors:  A L Marzo; R A Lake; D Lo; L Sherman; A McWilliam; D Nelson; B W Robinson; B Scott
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

2.  Transplantation tolerance induced by intranasal administration of HY peptides.

Authors:  Jian-Guo Chai; Edward James; Hamlata Dewchand; Elizabeth Simpson; Diane Scott
Journal:  Blood       Date:  2004-01-15       Impact factor: 22.113

Review 3.  Immune recognition of self in immunity against cancer.

Authors:  Alan N Houghton; José A Guevara-Patiño
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 4.  The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning.

Authors:  E Simpson; D Scott; P Chandler
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

5.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

Authors:  S Sakaguchi; N Sakaguchi; M Asano; M Itoh; M Toda
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

6.  Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

Authors:  J Shimizu; S Yamazaki; S Sakaguchi
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

7.  Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro.

Authors:  I C Summerhayes; L M Franks
Journal:  J Natl Cancer Inst       Date:  1979-04       Impact factor: 13.506

8.  Tumor regulatory T cells potently abrogate antitumor immunity.

Authors:  Zuqiang Liu; Jin H Kim; Louis D Falo; Zhaoyang You
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

9.  Are major histocompatibility complex molecules involved in the survival of naive CD4+ T cells?

Authors:  Isabelle Grandjean; Livine Duban; Elizabeth A Bonney; Erwan Corcuff; James P Di Santo; Polly Matzinger; Olivier Lantz
Journal:  J Exp Med       Date:  2003-09-29       Impact factor: 14.307

10.  Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells.

Authors:  Mary Jo Turk; José A Guevara-Patiño; Gabrielle A Rizzuto; Manuel E Engelhorn; Shimon Sakaguchi; Alan N Houghton
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

View more
  3 in total

1.  The desmoplastic stroma plays an essential role in the accumulation and modulation of infiltrated immune cells in pancreatic adenocarcinoma.

Authors:  Vegard Tjomsland; Lina Niklasson; Per Sandström; Kurt Borch; Henrik Druid; Charlotte Bratthäll; Davorka Messmer; Marie Larsson; Anna Spångeus
Journal:  Clin Dev Immunol       Date:  2011-12-06

Review 2.  Regulatory T cell: a protection for tumour cells.

Authors:  Yi Wang; Yushui Ma; Ying Fang; Shengdi Wu; Lili Liu; Da Fu; Xizhong Shen
Journal:  J Cell Mol Med       Date:  2012-03       Impact factor: 5.310

Review 3.  Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.

Authors:  Pablo A González; Leandro J Carreño; Pablo F Céspedes; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Clin Dev Immunol       Date:  2013-03-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.